Skip to main content
SpringerLink
Log in

Suggestions for maximising value for money for PBAC

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Carter D, et al. Governments Need Better Guidance to Maximise Value for Money: The Case of Australia's Pharmaceutical Benefits Advisory Committee. Applied Health Economics and Health Policy : 27 Jan 2016. Available from: URL: http://doi.org/10.1007/s40258-015-0220-3

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suggestions for maximising value for money for PBAC. PharmacoEcon Outcomes News 746, 11 (2016). https://doi.org/10.1007/s40274-016-2789-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2789-7

Search

Navigation